Fixed-Dose Combinations Pragmatic Randomized Implementation Trial for Blood Pressure Control

Starting soon · Not applicable

Conditions studied: Hypertension, Primary Care

In brief

The proposed study is an effectiveness-implementation hybrid type II trial designed to evaluate the impact of provider- and patient-directed interventions on FDC use. The trial will test the effectiveness of theory-driven nudges tailored to address provider and patient barriers. All interventions will be pharmacist-driven, with pharmacists delivering information via nudges to providers and via nudges or more intensive interventions (i.e., CPA) to patients. Data to evaluate outcomes will be extracted from electronic health records.

Key facts

Study ID
NCT07228065
Run by
Brigham and Women's Hospital
People needed
720
Starts
2026-07-31
Expected to finish
2027-06-30
Last updated by the study team
2026-06-18

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.